I'll give two examples that are quite important. In the area of medical gowns, the bottleneck that we had to solve was the provision of a textile to make the medical gown that would have the level of protection required in the hospital setting.
In this case we worked with Intertape Polymer and Autoliv, two companies that don't provide textiles typically for this kind of product. One is actually used for house wrap and one is used for car airbags. Those companies went through testing to ensure that their product, the textile created, when put in gown form would provide the level of protection required in the hospital setting. Those two products are now allowing us to unlock a huge scale-up of seven million or more gowns, which are being made from Canadian fibres. Therefore, we're solving that supply chain for medical gowns, which was a critical issue, to meet the needs of the front line.
That is also important in terms of sanitizer. We've connected with distillers and alternative support to create sanitizer and we've now been able to procure over 10 million litres of sanitizer from some Canadian sources that were not previously available. It's a very large-scale redirection of productive capacity to the needs of the front line.
I could add masks, surgical masks, to that as well, and also the face shields. We've seen a number of companies that have been able to use a common design, which is approved, and scale this up across their operations. Particularly the automotive suppliers have been very relevant. There's a lot of capability there in terms of plastic and large-scale manufacturing, and they've been able to successfully redirect their efforts to provide this critical PPE.